Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts

Senores Pharmaceuticals Ltd

NSE: SENORES · BSE: 544319 · Pharmaceuticals & Biotechnology · 40 announcements

Share price
₹1,398.00
Market cap
₹6,438 Cr
Revenue (annual)
₹632.6 Cr
Net profit (annual)
₹115.4 Cr
P/E (TTM)
51.0×Sector 47.4×
Promoter holding
45.82%+0.00% QoQ
FII holding
6.62%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 6Earnings Call 5Merger & Restructuring 4Financial Results 4Annual General Meeting 4Management Change 3Results Update 2Fund Raise 2Debt & Borrowing 2Board Meeting Date 2Results Correction 1Promoter Selling (Off-Market) 1Promoter Buying (Off-Market) 1Price Movement Clarification 1Business Update 1Annual Report 1

Time

All time Last 1 weekLast 1 monthLast 2 monthsLast 3 monthsLast 6 monthsLast 1 year

2 announcements with these filters

19:44 IST BSE
Fund Raise

Senores Pharmaceuticals Fund Raise of ₹100 Cr

Senores Pharmaceuticals approved revised utilisation of ₹100 Crore from unutilised IPO proceeds. The change is subject to shareholder approval via postal ballot.

Value
₹100.0 Cr
Read the filing ↗
15:25 IST NSE
Fund Raise

Senores Pharmaceuticals Fund Raise of ₹500 Cr

Senores Pharmaceuticals Limited submitted its Monitoring Agency Report for the Rs.500 Crore IPO proceeds. The filing confirms fund deployment for objects including debt repayment and growth.

Value
₹500.0 Cr
Read the filing ↗